Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma
Open Access
- 1 June 1998
- Vol. 53 (6), 483-489
- https://doi.org/10.1136/thx.53.6.483
Abstract
BACKGROUND Nitric oxide (NO) may be bronchoprotective in asthma, possibly due to a direct action on airway smooth muscle or through mast cell stabilisation. To investigate this the effects of two doses of nebulised NG-nitro-l-arginine methyl ester (l-NAME), a non-selective NO synthase (NOS) inhibitor, on exhaled NO levels and airway responsiveness to histamine, a direct smooth muscle spasmogen, and adenosine-5′-monophosphate (AMP), an indirect spasmogen which activates mast cells, were evaluated in patients with mild asthma. METHODS The study consisted of two phases each with a double blind, randomised, crossover design. In phase 1, 15 subjects inhaled either l-NAME 54 mg or 0.9% saline 30 minutes before histamine challenge. Nine of these subjects were studied in a similar fashion but were also challenged with AMP. In phase 2, 13 subjects (eight from phase 1) performed the same protocol but inhaledl-NAME in a dose of 170 mg or 0.9% saline before being challenged with histamine and AMP. RESULTS The mean (95% CI) reduction in exhaled NO levels after l-NAME 54 mg was 78% (66 to 90) but this did not alter airway responsiveness; the geometric mean (SE) concentration provoking a fall of 20% or more in forced expiratory volume in one second (PC20) after l-NAME and saline was 0.59 (1.26) and 0.81 (1.26) mg/ml, respectively, for histamine and 20.2 (1.7) and 17.2 (1.6) mg/ml, respectively, for AMP. In contrast,l-NAME 170 mg reduced NO levels to a similar extent (81% (95% CI 76 to 87)) but increased airway responsiveness by approximately one doubling dose to both spasmogens; the geometric mean (SE) PC20 for histamine after l-NAME 170 mg and saline was 0.82 (1.29) and 1.78 (1.19) mg/ml, respectively (pCONCLUSIONS These results suggest thatl-NAME increases airway responsiveness in asthma. This may occur through mechanisms separate from NO inhibition or through pathways independent of those responsible for production of NO measured in exhaled air.Keywords
This publication has 26 references indexed in Scilit:
- Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthmaThe Lancet, 1996
- Nitric Oxide and Airway DiseaseAnnals of Medicine, 1995
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994
- Induction of nitric oxide synthase in asthmaThe Lancet, 1993
- Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.Journal of Clinical Investigation, 1993
- New concepts in the pathogenesis of bronchial hyperresponsiveness and asthmaJournal of Allergy and Clinical Immunology, 1989
- Asthma and mast cell activationJournal of Allergy and Clinical Immunology, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Adenosine-induced bronchoconstriction in asthma: Role of mast cell-mediator releaseJournal of Allergy and Clinical Immunology, 1985
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975